Emma, living with Dravet syndrome
Taking FINTEPLA since 2022
To help you learn more about FINTEPLA, see below for answers to commonly asked questions. When you’re ready, talk to your healthcare provider to decide if FINTEPLA is right for you or your loved one.
About FINTEPLA
FINTEPLA is a prescription medicine used to treat the seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older.
It is not known if FINTEPLA is safe and effective in children less than 2 years of age.
FINTEPLA is a cherry-flavored liquid that is taken by mouth (administered orally) and can be taken with or without food. Read the Instructions for Use at the end of the FINTEPLA Medication Guide for information on the right way to take FINTEPLA.
FINTEPLA is available only through the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS). Some adults who took FINTEPLA developed problems with their heart valves that caused valvular heart disease or high blood pressure in the arteries of their lungs. FINTEPLA REMS is designed to help manage these potential safety concerns.
Before your loved one receives FINTEPLA, your healthcare provider will check their heart valves and lung artery pressure with a test called an echocardiogram (echo), which is an ultrasound picture of the heart. After enrolling in the FINTEPLA REMS and reviewing your loved one’s echo results, you and your healthcare provider will decide whether to begin FINTEPLA.
Yes, UCB offers the ONWARD® Copay Assistance Program for eligible commercially insured patients once they have been prescribed FINTEPLA.
For more information about financial assistance programs, please call ONWARD at 1-888-964-3649.
Taking FINTEPLA
During clinical studies, patients were on their current treatment plans, including other antiseizure medicines or treatments, such as use of a vagal nerve stimulator or ketogenic diet, while taking FINTEPLA. If you have additional questions about taking other medicines with FINTEPLA, speak with your healthcare provider.
Yes. FINTEPLA can be taken with commercially available CBD. If you have additional questions, speak with your healthcare provider.
Yes. There are no restrictions for use of FINTEPLA while on a ketogenic diet. In fact, patients on a ketogenic diet were included in the FINTEPLA clinical trials. Remember to discuss with your healthcare provider all treatments you may be taking, including the ketogenic diet.
Yes. FINTEPLA is compatible with feeding tubes. If you have additional questions, speak with your healthcare provider.
For patients with Dravet syndrome treated with FINTEPLA, the most common side effects include decreased appetite; diarrhea; low energy; respiratory infection; decreased weight; fever; constipation; abnormal echocardiogram; sleepiness; problems with movement, balance, and walking; increased drooling; increased blood pressure; vomiting; falls; seizures that do not stop; weakness.
Some patients in the clinical studies experienced a decrease in appetite and weight. However, most patients with Dravet syndrome and approximately half of patients with LGS resumed expected weight gains during the open-label extension study. If you have additional questions, speak with your healthcare provider.
